CSS
AVXL icon

Cubist Systematic Strategies’s Anavex Life Sciences AVXL Stock Holding History

Cubist Systematic Strategies’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,993
Closed -$475K – 3704
2023
Q4 		$475K Buy
+50,993
New +$351K ﹤0.01% 2551
2023
Q1 		– Sell
-119,600
Closed -$1.11M – 3894
2022
Q4 		$1.11M Sell
119,600
-5,872
-5% -$62.7K 0.01% 2350
2022
Q3 		$1.29M Buy
125,472
+91,979
+275% +$971K 0.01% 2402
2022
Q2 		$335K Sell
33,493
-23,787
-42% -$225K ﹤0.01% 3357
2022
Q1 		$705K Buy
57,280
+46,888
+451% +$577K 0.01% 2298
2021
Q4 		$180K Sell
10,392
-4,000
-28% -$76K ﹤0.01% 3064
2021
Q3 		$258K Sell
14,392
-23,596
-62% -$470K ﹤0.01% 2442
2021
Q2 		$868K Buy
37,988
+27,158
+251% +$402K 0.01% 1677
2021
Q1 		$162K Buy
+10,830
New +$118K ﹤0.01% 2536
2020
Q4 		– Sell
-11,684
Closed -$53K – 2555
2020
Q3 		$53K Sell
11,684
-6,133
-34% -$26.4K ﹤0.01% 2360
2020
Q2 		$88K Buy
+17,817
New +$67.3K ﹤0.01% 2216
2016
Q1 		– Sell
-17,570
Closed -$98K – 1601
2015
Q4 		$98K Buy
+17,570
New +$125K 0.01% 1512

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cubist Systematic Strategies's AVXL Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Anavex Life Sciences (AVXL) in Q1 2024, closing a stake of 50,993 shares — an estimated $475K sold.

Cubist Systematic Strategies first reported a position in AVXL in Q4 2015 and held it in 12 quarters. The position peaked at $1.29M in Q3 2022. 147 funds tracked by Wall St. Rank hold AVXL as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining Anavex Life Sciences position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 50,993 Anavex Life Sciences shares in Q1 2024, an estimated $475K.
  • Cubist Systematic Strategies first reported a position in Anavex Life Sciences in Q4 2015 and held it in 12 quarters.
  • Cubist Systematic Strategies's Anavex Life Sciences position peaked at $1.29M in Q3 2022.
  • 147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.